reference/26140179

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/26140179

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural
endingPage	233
issn	1538-4047 1555-8576
issueIdentifier	2
pageRange	228-233
publicationName	Cancer Biology & Therapy
startingPage	228
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_84f78546c707945e78f13b2302852b24 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c242e9e1052da35410a8eb5046047eed http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2ae6d9bf50d406a8f846301101608644
bibliographicCitation	Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry. Cancer Biol Ther. 2006 Feb;5(2):228–33. doi: 10.4161/cbt.5.2.2510. PMID: 16481735.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d73875f786e9c01add0e5cba391444f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4699c9b455fb7d7f14f25c2e0b6c30b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dd23b35727c238d435d9306c3c6e16c2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_143066fe1c5427bc030a8103877db4b1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7b2f5307479b763b6cef85c5d9a9da16 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6785cd4ebf76eff307d080e51d930898
date	200602
identifier	https://doi.org/10.4161/cbt.5.2.2510 https://pubmed.ncbi.nlm.nih.gov/16481735
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/29779 https://portal.issn.org/resource/ISSN/1538-4047 https://portal.issn.org/resource/ISSN/1555-8576
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry
discusses	http://id.nlm.nih.gov/mesh/M0024087 http://id.nlm.nih.gov/mesh/M0180256 http://id.nlm.nih.gov/mesh/M0025055 http://id.nlm.nih.gov/mesh/M0024234 http://id.nlm.nih.gov/mesh/M0022203 http://id.nlm.nih.gov/mesh/M0181712 http://id.nlm.nih.gov/mesh/M0250097
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D036104Q000378 http://id.nlm.nih.gov/mesh/D008545Q000098 http://id.nlm.nih.gov/mesh/D009389Q000378 http://id.nlm.nih.gov/mesh/D012878Q000098 http://id.nlm.nih.gov/mesh/D015820Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D014443Q000378 http://id.nlm.nih.gov/mesh/D002462Q000737 http://id.nlm.nih.gov/mesh/D007365Q000378 http://id.nlm.nih.gov/mesh/D036382Q000378 http://id.nlm.nih.gov/mesh/D002462Q000378 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D012878Q000378 http://id.nlm.nih.gov/mesh/D008545Q000378 http://id.nlm.nih.gov/mesh/D007365Q000737 http://id.nlm.nih.gov/mesh/D003593Q000737 http://id.nlm.nih.gov/mesh/D016376Q000235 http://id.nlm.nih.gov/mesh/D016376Q000494 http://id.nlm.nih.gov/mesh/D003593Q000378 http://id.nlm.nih.gov/mesh/D036104Q000235 http://id.nlm.nih.gov/mesh/D002448 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D015398 http://id.nlm.nih.gov/mesh/D015820Q000032 http://id.nlm.nih.gov/mesh/D015703 http://id.nlm.nih.gov/mesh/D036104Q000032
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6057 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5d0f9cac1efbeec6502f1d2db8ff6855 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3df5a8bd5c6526737baf69574b57602c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4b314c92a79e626165622f7b6869f840

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1003 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128865459 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1969

Total number of triples: 70.